Table 4.

Comparative analysis of renal function between 20 ADPKD patients and 17 CKD patients at baseline T0 and after SARS-CoV2 infection (T1). All results are expressed as median and interquartile range (IQR).

	T0			T1
	ADPKD	CKD	p	ADPKD	CKD	p
Creatinine, mg/dL	1.8 (1.5; 2)	1.7 (1.3; 2.3)	>0.05	2.2 (1.6; 2.4)	1.5 (1.1; 1.9)	>0.05
eGFR, mL/min	42.5 (39.7; 46.3)	37 (27; 54)	>0.05	33.5 (26; 44.2)	41 (33; 65)	>0.05
	Variation T1–T0
	ADPKD			CKD		p
Creatinine, mg/dL	0.29 (0.12; 0.5)			−0.16 (−0.3; 0)		<0.001
eGFR, mL/min	−6.5 (−16.25; −1.25)			4 (0; 19)		<0.001

ADPKD: Autosomal Dominant Polycystic Kidney Disease; CKD: Chronic Kidney Disease; eGFR: estimated Glomerular Filtration Rate.